Targeted next-generation sequencing: a novel diagnostic tool for primary immunodeficiencies

Area of Science:

• Genetics
• Immunology
• Bioinformatics

Background:

• Primary immunodeficiency (PID) disorders stem from inherited monogenetic immune defects.
• Over 170 genes are linked to PIDs, but genotype-phenotype correlations are often unclear, complicating genetic diagnosis.
• Current diagnostic methods for PIDs can be complex and time-consuming.

Purpose of the Study:

• To develop a robust, time-effective, and cost-effective next-generation sequencing (NGS) method.
• To facilitate genetic diagnosis for any of the 170 known PID-related genes.
• To improve the diagnostic yield for patients with undiagnosed primary immunodeficiencies.

Main Methods:

• Employed targeted array-based and in-solution enrichment techniques.
• Utilized a SOLiD sequencing platform and an in-house developed bioinformatic pipeline.
• Analyzed DNA from 41 patients with known PID mutations and 26 with undiagnosed PIDs.

Main Results:

• Achieved high accuracy for point mutations (>99% sensitivity/specificity) and exonic deletions (100% sensitivity/specificity).
• Provided >20× DNA coverage for 90-95% of the 170 genes of interest.
• Successfully made genetic diagnoses in 4 of 26 previously undiagnosed patients, including 3 with atypical presentations.

Conclusions:

• The novel NGS tool enables accurate, simultaneous detection of mutations in 161 of 170 known PID-related genes.
• This method simplifies and accelerates the genetic diagnosis of primary immunodeficiencies.
• The analyses are expected to enhance understanding of genotype-phenotype correlations in PID disorders.